Executive Change: Retension Pharmaceuticals Appoints Alex Schwartz as Chief Financial Officer
Falls Church, VA – Retension Pharmaceuticals has announced the appointment of Alex Schwartz as Chief Financial Officer. About Retension Pharmaceuticals: Retension Pharmaceuticals is a clinical-stage biopharmaceutical company focused on developing effective treatments to optimize blood…